FY 2025
Loading financial data...
|
Chart |
FY21
Dec 31, 2021
|
FY22
Dec 31, 2022
|
FY23
Dec 31, 2023
|
FY24
Dec 31, 2024
|
FY25
Dec 31, 2025
|
TTM
Trailing 12M
|
|---|---|---|---|---|---|---|---|
|
Revenue
Total sales generated. |
|
$46.39 B | $46.16 B | $45.01 B | $48.30 B | $48.19 B | $48.48 B |
|
Cost of Revenue Direct cost of goods/services. |
|
$19.62 B | $19.67 B | $19.65 B | $20.87 B | $15.59 B | $15.15 B |
Gross Profit Revenue minus cost of revenue. |
|
$26.76 B | $26.49 B | $25.36 B | $27.43 B | $32.60 B | $33.33 B |
|
Operating Expense
Costs to run business. 
|
|
$17.22 B | $17.22 B | $16.89 B | $17.77 B | $19.91 B | $20.88 B |
Operating Income Profit from operations. |
|
$9.54 B | $9.27 B | $8.47 B | $9.66 B | $12.70 B | $12.45 B |
|
Net Interest Income
Interest income minus expense.
|
|
-$1.33 B | -$1.23 B | -$1.17 B | -$1.95 B | -$1.21 B | -$716.00 M |
Non-Operating Income (ex-Int) Income outside core operations. |
|
$108.00 M | $326.00 M | -$1.13 B | $16.09 B | $2.01 B | $1.96 B |
Total Other Income (Net) Net non-operating items. |
|
-$1.44 B | -$1.56 B | -$32.00 M | -$18.04 B | -$3.37 B | -$2.85 B |
Income Before Tax Profit before taxes. |
|
$8.10 B | $7.71 B | $8.44 B | -$8.38 B | $9.33 B | $9.60 B |
Income Tax Expense Taxes on income. |
|
$1.08 B | $1.37 B | $400.00 M | $554.00 M | $2.27 B | $2.32 B |
|
Net Income
Final profit.
|
|
$6.99 B | $6.33 B | $8.03 B | -$8.95 B | $7.05 B | $7.28 B |
|
Earnings Per Share
Company profit allocated to each outstanding share. |
|||||||
EPS Earnings per share. Formula: Net Income ÷ Shares |
|
$3.15 | $2.97 | $3.88 | -$4.41 | $3.46 | $3.56 |
Diluted EPS EPS including dilution. Formula: Net Income ÷ Diluted Shares |
|
$3.12 | $2.95 | $3.86 | -$4.41 | $3.45 | $3.56 |
|
Shares for EPS
Number of shares used to calculate EPS. |
|||||||
Weighted Average Shares Outst. Avg shares used for EPS. |
|
2.22 B | 2.13 B | 2.07 B | 2.03 B | 2.04 B | 2.04 B |
Diluted Average Shares Outst. Shares including dilution. |
|
2.25 B | 2.15 B | 2.08 B | 2.03 B | 2.04 B | 2.04 B |
| Supplemental Items | |||||||
EBIT Earnings before interest and tax. |
|
$9.43 B | $8.95 B | $9.61 B | -$6.43 B | $10.68 B | $10.49 B |
EBITDA Earnings before interest, tax, D&A. |
|
$20.12 B | $19.22 B | $19.37 B | $3.17 B | $14.55 B | $13.78 B |
Depreciation and Amortization Non-cash expense for assets. |
|
$10.69 B | $10.28 B | $9.76 B | $9.60 B | $3.86 B | $3.29 B |
| Company Report |
FY 2025
Bristol-Myers Squibb Company's Balance Sheet
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
| Loading balance sheet when needed... |
Bristol-Myers Squibb Company's Cash flow
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
| Loading cash flow statement when needed... |
Bristol-Myers Squibb Company's Profitability
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
| Loading profitability metrics when needed... |
Bristol-Myers Squibb Company's Ratios
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
